About The Team We’re a tight-knit team of proven drug hunters, deep learning researchers, and software engineers united by a common mission — drive AI innovation in biochemistry, discovering and developing groundbreaking therapies for patients suffering from severe disorders.
Genesis AI team is focused on developing foundation models for drug discovery by conducting fundamental research at the intersection of machine learning, physics, and computational chemistry, as well as engineering robust software systems that enable running large scale simulations and training generative and predictive AI models designed to learn from all kinds of molecular data, leveraging our cluster with 1000s of GPUs and 10,000s of CPUs.
About The Role We’re seeking an experienced ML Research Scientist to shape and lead the ML research agenda for generative modeling of molecular systems, which is instrumental to our mission. You will be at the forefront of pioneering research initiatives, driving the continuous evolution and enhancement of our AI platform, while collaborating with exceptional engineers, researchers, and a team of biochemistry experts.
Positions are available at various levels of seniority: Senior, Staff, and Principal.
You will
Lead transformative research projects that enhance the Genesis AI platform's capabilities, focusing on generative models for molecular systems
Navigate the latest deep learning literature, extracting insights from generative modeling in adjacent domains (language, images, 3D graphics, etc.), develop novel models and training techniques for molecular data, and communicate your findings to the team
Carefully design and run experiments at scale to validate most promising approaches and work closely with engineers to ship state-of-the-art models to production
Contribute to the research community by publishing some of our findings in the form of research papers and blog posts at top tier AI/ML venues (NeurIPS, ICML, ICLR, etc.), attending conferences and workshops, and engaging in continuous learning and knowledge exchange
Have the opportunity to mentor and guide more junior members of our technical team as well as research interns, fostering an environment of growth and innovation
You are
A deep learning expert with a track record of doing novel research in one or more of the following domains: denoising diffusion, normalizing flows, flow matching, neural ODEs and SDEs, or other cutting edge generative or predictive machine learning models
Independent thinker with a strong sense of ownership and capability of driving research ideas from first-principles-based conceptualization to state-of-the-art realization
Strong coder who is not afraid of deep dives into engineering whenever necessary
Curious, problem-oriented thinker who is excited to dive deep into the emerging field at the intersection of AI, physics, chemistry, and biology and make foundational contributions and discoveries (no previous experience in anything but ML necessary)
Nice to haves
PhD in machine learning, computer science, other computational sciences or equivalent research experience and strong publication record at top tier ML venues are preferred
Hands-on experience with some of the core libraries we use: Pytorch, Pytorch Lightning, Pytorch Geometric
Experience in distributed training and inference of large models on GPU clusters
Experience working with some of the following: molecular systems (protein sequences and 3D structures, small molecules, etc.), ML force fields or other physics-informed models and methods, or point cloud data in other application domains, such as 3D graphics
Compensation, Benefits, And Perks
Competitive compensation package that includes salary and equity
Comprehensive health benefits: Medical, Dental, and Vision (covered 100% for the employees)
401(k) plan
Open (unlimited) PTO policy
Free lunches and dinners at our offices
Paid family leave (maternity and paternity)
Life and long- and short-term disability insurance
About Genesis Therapeutics Genesis Therapeutics is unifying AI and biotech to discover novel and breakthrough treatments for patients with severe and devastating conditions. Genesis was founded on groundbreaking molecular ML research and since has established itself as the industry leader in AI for small molecule drug discovery. Our team of accomplished biotech leaders and expert drug hunters joins forces with deep learning researchers and software engineers who are pioneering predictive and generative AI technologies for molecules.
Our team has created the industry's most advanced molecular AI platform called GEMS (Genesis Exploration of Molecular Space), to accelerate and optimize small molecule drug discovery and to enable the discovery of novel first-in-class and best-in-class small molecule drugs for challenging and/or undruggable targets.
The company has leveraged GEMS to build an internal pipeline with multiple programs against high-value targets, including data-poor and canonically undruggable targets where GEMS is uniquely advantaged. In addition, Genesis has two AI platform collaborations across a range of therapeutic areas: Eli Lilly (signed in 2022, with a $20M upfront payment and a $670M total deal size), and Genentech (signed in 2020).
We raised a $200M series B in August 2023, and have raised over $280M in funding from top technology and biotech investors, including Andreessen Horowitz, Rock Springs Capital, T. Rowe Price, Fidelity, Radical Ventures, NVentures (NVIDIA's VC arm), BlackRock, and Menlo Ventures.
Genesis is headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego. We are proud to be an inclusive workplace and an Equal Opportunity Employer.
Finding the best talent is our top priority at Genesis Therapeutics. If you are interested in potential partnership on recruitment, please reach out to recruiting@genesistherapeutics.ai.
Seniority level
Not Applicable
Employment type
Full-time
Job function
Other
Industries
Transportation, Logistics, Supply Chain and Storage, Internet Publishing, and Internet Publishing
Referrals increase your chances of interviewing at Genesis Therapeutics by 2x